All News
Filter News
Found 808,606 articles
-
ImmunoGen, Inc. Announces Presentation At American Society of Hematology Of Encouraging Findings With HuN901-DM1 For The Treatment Of Multiple Myeloma
12/11/2006
-
Merck & Co., Inc. And Vertex Pharmaceuticals Incorporated Announce Phase I Results For Investigational Aurora Kinase Inhibitor MK-0457 (VX-680); Compound Showed Activity In Patients With Treatment-Resistant Forms Of Advanced Leukemias And Myeloproliferati
12/11/2006
-
Preliminary Results From Sunesis Pharmaceuticals, Inc.'s Phase 1 Trial Of SNS-595 In Patients With Advanced Leukemias Demonstrate Promising Clinical Activity
12/11/2006
-
KOSAN Biosciences, Inc.'s Lead Hsp90 Inhibitor, Tanespimycin, Shows Antitumor Activity In Multiple Myeloma
12/11/2006
-
Immunomedics, Inc. Release: Low Doses Of Humanized Anti-Cd20 Antibody Reported Active In Non-Hodgkin's Lymphoma
12/11/2006
-
Cytogen Corporation Release: Data From Phase 1 Dose Escalation Study Of QUADRAMET(R) And Bortezomib In Patients With Relapsed Multiple Myeloma Presented At The American Society of Hematology Annual Meeting
12/11/2006
-
Gemin X Biotechnologies Inc. Phase 1 Data Show Clinical Activity Of GX15-070 In Myelodysplastic Syndromes
12/11/2006
-
Merck & Co., Inc. And Vertex Pharmaceuticals Incorporated Announce Phase I Results For Investigational Aurora Kinase Inhibitor MK-0457 (VX-680); Compound Showed Activity In Patients With Treatment- Resistant Forms Of Advanced Leukemias And Myeloproliferat
12/11/2006
-
Ortho Biotech Products, L.P. Analysis From Real-World Drug Administration Data Suggests Lower Drug Cost For PROCRIT(R) (Epoetin Alfa) In Outpatient Setting
12/11/2006
-
KOSAN Biosciences, Inc.'s Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows Antitumor Activity In Refractory Leukemia
12/11/2006
-
GPC Biotech AG Presents Preliminary Clinical Data On Anticancer Monoclonal Antibody 1D09C3 At American Society of Hematology
12/11/2006
-
Novacea Announces Positive AQ4N Phase 1 Study In Lymphoma At American Society of Hematology Annual Meeting
12/11/2006
-
Imagenetix, Inc. Receives FDA Clearance To Begin Pre-IND Safety Studies On Anti-Inflammatory Compound
12/11/2006
-
XOMA (US) LLC Announces Pre-Clinical And Clinical Progress On HCD122
12/11/2006
-
Telik, Inc. Announces Positive Data Demonstrating That TELINTRA(TM) Enhances Production Of G-CSF And GM-CSF
12/11/2006
-
Immunomedics, Inc. Release: Novel Protein Constructs Active Against Lymphoma In Animal Models
12/11/2006
-
Protalex, Inc. Lead Compound, PRTX-100, Inhibits Platelet Phagocytosis In Vitro
12/11/2006
-
Xanthus Pharmaceuticals, Inc. Presents Preclinical Data Demonstrating Potent Symadex Activity In Leukemia Cells
12/11/2006
-
Ariad Pharmaceuticals, Inc. Presents Preclinical Efficacy Data On AP24534, A Novel Oral Kinase Inhibitor For Drug-Resistant CML
12/11/2006
-
Baxter Healthcare Corporation Presents Preclinical Studies Of Experimental Longer-Acting Hemophilia A Therapy
12/11/2006